Notice: You are viewing an unstyled version of this page. Are you using a very old browser? If so, please consider upgrading


Dr Joris Hemelaar BM BCh BSc MSc DPhil MRCOG

Senior Clinical Research Fellow joris.hemelaar@ndph.ox.ac.uk

Biography

Joris Hemelaar is a Senior Clinical Research Fellow in the National Perinatal Epidemiology Unit (NPEU) within Oxford Population Health. Joris completed his BSc and MSc degrees in Molecular Biology and Genetics at Leiden University in his native the Netherlands. He subsequently obtained his BM BCh medical degree and DPhil in Immunology at Oxford and conducted post-doctoral research at the Harvard Medical School. He specialised in Obstetrics & Gynaecology, during which time he was an NIHR Academic Clinical Fellow and Clinical Lecturer in Oxford. In 2021 was appointed as an Honorary Consultant in Obstetrics at the John Radcliffe Hospital in Oxford. His research interests include adverse perinatal outcomes associated with maternal HIV infection and antiretroviral treatment, using evidence synthesis methods, cohort studies in South Africa, and laboratory analysis of biological samples. In addition, he studies the global molecular epidemiology of HIV, which is crucial for HIV vaccine development.

Publications

Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Kirtley S, Gouws-Williams E, Ghys PD, & WHO-UNAIDS Network for HIV Isolation and Characterisation. Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey. Lancet HIV, 7(11): e772-e781 (2020).

Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD & WHO-UNAIDS Network for HIV Isolation and Characterisation. Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. Lancet Infectious Diseases, 19(2): 143-155 (2019).

Wedi CO, Kirtley S, Hopewell S, Corrigan R, Kennedy SH, Hemelaar J. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV, 3(1): e33-48 (2016).